ABCL
Price
$2.44
Change
+$0.07 (+2.95%)
Updated
Jun 6 closing price
Capitalization
705.92M
65 days until earnings call
EDIT
Price
$1.91
Change
+$0.11 (+6.11%)
Updated
Jun 6 closing price
Capitalization
150.68M
52 days until earnings call
Interact to see
Advertisement

ABCL vs EDIT

Header iconABCL vs EDIT Comparison
Open Charts ABCL vs EDITBanner chart's image
AbCellera Biologics
Price$2.44
Change+$0.07 (+2.95%)
Volume$3.8M
Capitalization705.92M
Editas Medicine
Price$1.91
Change+$0.11 (+6.11%)
Volume$2.45M
Capitalization150.68M
ABCL vs EDIT Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. EDIT commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and EDIT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ABCL: $2.04 vs. EDIT: $1.87)
Brand notoriety: ABCL and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 62% vs. EDIT: 144%
Market capitalization -- ABCL: $705.92M vs. EDIT: $150.68M
ABCL [@Biotechnology] is valued at $705.92M. EDIT’s [@Biotechnology] market capitalization is $150.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 6 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • EDIT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +2.51% price change this week, while EDIT (@Biotechnology) price change was +24.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

EDIT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($706M) has a higher market cap than EDIT($151M). EDIT YTD gains are higher at: 47.244 vs. ABCL (-30.375). ABCL has higher annual earnings (EBITDA): -204.15M vs. EDIT (-233.11M). ABCL has more cash in the bank: 626M vs. EDIT (270M). EDIT has less debt than ABCL: EDIT (35M) vs ABCL (65.4M). EDIT has higher revenues than ABCL: EDIT (32.3M) vs ABCL (28.8M).
ABCLEDITABCL / EDIT
Capitalization706M151M468%
EBITDA-204.15M-233.11M88%
Gain YTD-30.37547.244-64%
P/E RatioN/AN/A-
Revenue28.8M32.3M89%
Total Cash626M270M232%
Total Debt65.4M35M187%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLEDIT
RSI
ODDS (%)
Bullish Trend 11 days ago
85%
Bearish Trend 11 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
78%
Bearish Trend 11 days ago
85%
Momentum
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
88%
Bullish Trend 11 days ago
77%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 24 days ago
86%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
73%
Bearish Trend 11 days ago
88%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+3.03%
CRSP - ABCL
61%
Loosely correlated
-0.92%
ABSI - ABCL
59%
Loosely correlated
+0.74%
RXRX - ABCL
59%
Loosely correlated
+0.11%
NTLA - ABCL
57%
Loosely correlated
+3.59%
BEAM - ABCL
57%
Loosely correlated
-0.88%
More

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+13.33%
CRSP - EDIT
54%
Loosely correlated
-0.92%
NTLA - EDIT
50%
Loosely correlated
+3.59%
PRME - EDIT
49%
Loosely correlated
N/A
ABCL - EDIT
47%
Loosely correlated
+3.03%
RXRX - EDIT
47%
Loosely correlated
+0.11%
More